UK Markets close in 4 hrs 48 mins

Renhe Pharmacy Co., Ltd (000650.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
6.58-0.10 (-1.50%)
At close: 4:29PM CST

Renhe Pharmacy Co., Ltd

No.998, Honggu Avenue
18th Floor Yuanchuang International, B District Of The Centra Honggutan New District
Nanchang 330038
China
86 791 8389 6755
http://www.renheyaoye.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees6,886

Key executives

NameTitlePayExercisedYear born
Mr. Wei ZhangGM & Non-Independent DirectorN/AN/A1964
Mr. Qiu Lin PengCFO & Non-Independent DirectorN/AN/A1966
Mr. Zi Qiang ZhangDeputy GM & Non-Independent DirectorN/AN/A1971
Mr. Zhen WangDeputy Gen. Mang.N/AN/A1975
Mr. Feng JiangSec. of the Board of DirectorsN/AN/A1976
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Renhe Pharmacy Co., Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines; chemical drugs; dietary supplements; and active pharmaceutical ingredients. It also provides health related products, such as oral solid and liquid dosages, large and small volume injections, lotions for external use, liniments, suppositories, and ointments; and eye drops, bulk medicines, hard and soft capsules, and granules tablets. The company was founded in 1996 and is based in Nanchang, China.

Corporate governance

Renhe Pharmacy Co., Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more